Gary S Rubin Selected Research

Scotoma (Scintillating Scotoma)

4/2015	Simulation contact lenses for AMD health state utility values in NICE appraisals: a different reality.
2/2011	Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter.
1/2011	Task-specific fixation behavior in macular disease.
11/2006	Reading with central scotomas: is there a binocular gain?
9/2005	Preferred retinal locus development in patients with macular disease.
12/2004	Fixation stability using central and pericentral fixation targets in patients with age-related macular degeneration.
7/2004	Fixation stability and reading speed in patients with newly developed macular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary S Rubin Research Topics

Disease

16	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 10/2002
7	Scotoma (Scintillating Scotoma) 04/2015 - 07/2004
3	Cataract (Cataracts) 01/2020 - 03/2007
2	Retinal Detachment (Retinal Detachments) 04/2009 - 07/2008
2	Choroidal Neovascularization 04/2009 - 10/2002
1	Vision Disorders (Hemeralopia) 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2020
1	Blindness (Hysterical Blindness) 01/2020
1	Low Vision (Subnormal Vision) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Hyperpigmentation 11/2018
1	Leber Congenital Amaurosis 01/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 06/2017
1	Cone Dystrophy 04/2016
1	Stargardt Disease 01/2016
1	Retinal Diseases 04/2015
1	Glaucoma 11/2012
1	Retinal Degeneration 06/2010
1	Retinoschisis (Retinoschisis, Juvenile) 06/2010
1	Cone-Rod Dystrophies 06/2010
1	Enhanced S-Cone Syndrome 06/2010
1	Night Blindness (Nyctalopia) 06/2010
1	Epiretinal Membrane (Epiretinal Membranes) 04/2009
1	Myopia 02/2009
1	Early Onset Severe Retinal Dystrophy 05/2008
1	Telangiectasis (Telangiectasia) 03/2008

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 01/2019 - 07/2004
2	Fluorescein (Funduscein)FDA LinkGeneric 06/2017 - 03/2007
2	Bevacizumab (Avastin)FDA Link 06/2014 - 05/2011
1	Therapeutic UsesIBA 01/2022
1	afliberceptIBA 09/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Retinal Pigments (Pigments, Visual)IBA 11/2018
1	Ranibizumab (Lucentis)FDA Link 04/2015
1	Transcription Factors (Transcription Factor)IBA 06/2010
1	Proteins (Proteins, Gene)FDA Link 05/2008
1	Silicone OilsIBA 03/2007
1	Verteporfin (Visudyne)FDA Link 10/2002

Therapy/Procedure

4	Therapeutics 09/2020 - 10/2002
4	Lasers (Laser) 01/2020 - 12/2004
3	Telescopes 11/2012 - 11/2006
2	Transplantation 01/2020 - 11/2018
2	Contact Lenses 04/2015 - 02/2009
1	Injections 09/2020
1	Phacoemulsification 01/2020
1	Anesthesia 06/2017
1	Aftercare (After-Treatment) 04/2016
1	Multifocal Intraocular Lenses 12/2013
1	Lenses 12/2013
1	Cataract Extraction 07/2008
1	Autologous Transplantation 03/2007
1	Radiotherapy 12/2003
1	Photochemotherapy (Photodynamic Therapy) 10/2002